Stoke Therapeutics, Inc. (STOK) Balance Sheet
As of 2026-06-30 (10-Q), Stoke Therapeutics, Inc. (STOK) reported total assets of $394.0M, total liabilities of $48.4M and shareholders' equity of $345.5M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $110.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
STOKStoke Therapeutics, Inc.Follow STOK — free
—
Price chart with a free account
- Market cap
- 1.6B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 222.5 | 287.3 | 144.9 | 113.6 | 191.4 | 128.0 | 84.2 | 110.0 | |
| Short-term investments | — | 0.0 | 74.9 | 116.0 | 10.0 | 88.9 | 200.5 | 182.8 | |
| Receivables | — | — | — | — | — | 1.7 | 5.9 | 7.2 | |
| Current assets | 226.0 | 293.9 | 229.2 | 244.1 | 215.3 | 232.8 | 305.7 | 322.5 | |
| Total assets | 228.8 | 297.9 | 238.9 | 256.1 | 228.3 | 271.6 | 418.4 | 394.0 | |
| Current liabilities | 4.1 | 11.4 | 17.1 | 31.4 | 30.8 | 40.1 | 57.9 | 41.9 | |
| Total liabilities | 4.3 | 11.8 | 21.1 | 71.2 | 68.8 | 42.5 | 66.0 | 48.4 | |
| Shareholders' equity | 224.4 | 286.1 | 217.8 | 184.8 | 159.6 | 229.0 | 352.5 | 345.5 |
USD millions · SEC XBRL
Stoke Therapeutics, Inc. — questions
- How much cash does Stoke Therapeutics, Inc. have?
- $110.0M in cash and cash equivalents as of 2026-06-30.
- What are Stoke Therapeutics, Inc.'s total assets?
- $394.0M as of 2026-06-30.
- What is Stoke Therapeutics, Inc.'s shareholders' equity?
- $345.5M as of 2026-06-30.
Every figure on this page comes from Stoke Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.